| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Camp BJ |
The Alkaloid of Acacia berlandieri N-Methyl-B-Phenylethylamine : A dis... |
Graduate School of A... |
1956 |
| Cameron K |
Hallucinogenic drugs. Specific problems |
Lancet |
1961 |
| Woolley DW, Campbell NK |
Serotonin-like and antiserotonin properties of psilocybin and psilocin |
Science |
1962 |
| Cameron K |
Some experiences with LSD in the treatment of adolescent boys |
Hallucinogenic drugs... |
1963 |
| Martínez del Campo Enríqu... |
Acción farmacológica de la psilocibina |
Tesis |
1964 |
| DC Cameron |
Drug Dependence: No Longer Can We "Let George Do It" |
Amer. J. Psychiat. (... |
1966 |
| Adams HR, Camp BJ |
The isolation and identification of three alkaloids from Acacia Berlan... |
Toxicon |
1966 |
| Minghetti A, Arcamone F |
Studies concerning the biogenesis of natural derivatives of lysergic a... |
Experientia |
1969 |
| Campbell DB, Turner P |
Plasma concentrations of fenfluramine and its metabolite, norfenfluram... |
Br J Pharmacol |
1971 |
| Cameron OG, Appel JB |
Conditioned suppression of bar-pressing behavior by stimuli associated... |
J. exp. Anal. Behav. |
1972 |
| Cameron OG, Appel JB |
A behavioral and pharmacological analysis of some discriminable proper... |
Psychopharmacologia |
1973 |
| Campbell H, Cline W, Evan... |
Comparison of the effects of dexamphetamine and 1-benzylpiperazine in ... |
Eur J Clin Pharmacol |
1973 |
| Cameron OG, Appel JB |
Drug Induced Conditioned Suppression: Specificity Cue To Drug Employed... |
Pharmacol. Biochem. ... |
1976 |
| O'Brien BA, Bonicamp JM, ... |
Differentiation of Amphetamine and Its Major Hallucinogenic Derivative... |
J Anal Toxicol |
1982 |
| Marchant NC, Breen MA, Wa... |
Comparative biodisposition and metabolism of 14C-(+/-)-fenfluramine in... |
Xenobiotica |
1992 |
| Campkin NJ, Davies UM |
Treatment of 'ecstasy' overdose with dantrolene |
Anaesthesia |
1993 |
| Campbell DB |
The use of toxicokinetics for the safety assessment of drugs acting in... |
Mol Neurobiol |
1995 |
| Campbell DB |
Extrapolation from animals to man: the integration of pharmacokinetics... |
Ann N Y Acad Sci |
1996 |
| Donnelly-Roberts DL, Putt... |
ABT-594 [R-5-2-azetidinylmethoxy-2-chloropyridine]: a novel, orally ef... |
J Pharmacol Exp Ther |
1998 |
| Mas M, Farre M, de la Tor... |
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4... |
J Pharmacol Exp Ther |
1999 |
| Ortuno J, Pizarro N, Farr... |
Quantification of 3,4-methylenedioxymetamphetamine and its metabolites... |
J Chromatogr B Biome... |
1999 |
| Carvalho JC, Ferreira LP,... |
Anti-inflammatory activity of flavone and some of its derivates from V... |
J Ethnopharmacol |
1999 |
| Cording CJ, DeLuca R, Cam... |
A fatality related to the veterinary anesthetic telazol |
J Anal Toxicol |
1999 |
| de la Torre R, Farré M, O... |
Non-linear pharmacokinetics of MDMA (`ecstasy') in humans |
Br J Clin Pharmacol |
2000 |
| de la Torre R, Farre M, O... |
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans |
Br J Clin Pharmacol |
2000 |
| Cami J, Farre M, et al |
Human pharmacology of 3,4-methylenedioxymethamphetamine ('ecstasy'): p... |
J Clin Psychopharmac... |
2000 |
| de la Torre R, Farre M, R... |
Pharmacology of MDMA in humans |
Ann N Y Acad Sci |
2000 |
| Pacifici R, Zuccaro P, Fa... |
Immunomodulating activity of MDMA |
Ann N Y Acad Sci |
2000 |
| Sanchez V, Camarero J, Es... |
The mechanisms involved in the long-lasting neuroprotective effect of ... |
Br J Pharmacol |
2001 |
| Esteban B, O'Shea E, Cama... |
3,4-Methylenedioxymethamphetamine induces monoamine release, but not t... |
Psychopharmacology (... |
2001 |
| O'Shea E, Esteban B, Cama... |
Effect of GBR 12909 and fluoxetine on the acute and long term changes ... |
Neuropharmacology |
2001 |
| Colado MI, Camarero J, Me... |
A study of the mechanisms involved in the neurotoxic action of 3,4- me... |
Br J Pharmacol |
2001 |
| Farré M, Roset PN, de la ... |
Interaction of Paroxetine and MDMA in humans |
College on Problems... |
2002 |
| Byard RW, Rodgers NG, Jam... |
Death and paramethoxyamphetamine -- an evolving problem |
Med J Aust |
2002 |
| Campo JV, McNabb J, Perel... |
Kava-induced fulminant hepatic failure |
J Am Acad Child Adol... |
2002 |
| Hernandez-Lopez C, Farre ... |
3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions i... |
J Pharmacol Exp Ther |
2002 |
| Pizarro N, Ortuno J, Farr... |
Determination of MDMA and its metabolites in blood and urine by gas ch... |
J Anal Toxicol |
2002 |
| Camarero J, Sanchez V, O'... |
Studies, using in vivo microdialysis, on the effect of the dopamine up... |
J Neurochem |
2002 |
| Fergusson DM, Horwood LJ,... |
Cannabis dependence and psychotic symptoms in young people |
Psychol Med |
2003 |
| Sanchez V, Camarero J, O\... |
Differential effect of dietary selenium on the long-term neurotoxicity... |
Neuropharmacology |
2003 |
| Pubill D, Canudas AM, Pal... |
Different glial response to methamphetamine- and methylenedioxymethamp... |
Naunyn Schmiedebergs... |
2003 |
| Koprich JB, Chen EY, Kana... |
Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters explorator... |
Neurotoxicol Teratol |
2003 |
| Vallee JN, Crozier S, Gui... |
Acute basilar artery occlusion treated by thromboaspiration in a cocai... |
Neurology |
2003 |
| Cameron D |
Much, much more important than that |
Addiction Reasearch ... |
2003 |
| de la Torre R, Farre M, R... |
Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposit... |
Ther Drug Monit |
2004 |
| Farre M, De La Torre R, O... |
Repeated doses administration of MDMA in humans: pharmacological effec... |
Psychopharmacology (... |
2004 |
| Orio L, O'Shea E, Sanchez... |
3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels a... |
J Neurochem |
2004 |
| de la Torre R, Farre M, O... |
MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in ni... |
Eur J Clin Pharmacol |
2005 |
| Gobbi G, Bambico FR, Mang... |
Antidepressant-like activity and modulation of brain monoaminergic tra... |
pnas |
2005 |
| Campos AR, Santos FA, Rao... |
Ketamine-induced potentiation of morphine analgesia in rat tail-flick ... |
Biol Pharm Bull |
2006 |
| Camarasa J, Pubill D, Esc... |
Association of caffeine to MDMA does not increase antinociception but ... |
Brain Res |
2006 |
| Williams MT, Herring NR, ... |
Alterations in Body Temperature, Corticosterone, and Behavior Followin... |
Neuropsychopharmacol... |
2006 |
| Maeng S, Zarate CA, Du J,... |
Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine:... |
Biol Psychiatry |
2007 |
| McCambridge J |
A case study of publication bias in an influential series of reviews o... |
Drug Alcohol Rev |
2007 |
| Chipana C, Camarasa J, Pu... |
Memantine prevents MDMA-induced neurotoxicity |
Neurotoxicology |
2008 |
| Camarasa J, Marimon JM, R... |
Memantine prevents the cognitive impairment induced by 3,4-methylenedi... |
Eur J Pharmacol |
2008 |
| Greely H, Sahakian B, Har... |
Towards responsible use of cognitive-enhancing drugs by the healthy |
Nature |
2008 |
| Tadini KA, Campos PM |
In vivo skin effects of a dimethylaminoethanol (DMAE) based formulatio... |
Pharmazie |
2009 |
| Camilleri A, Johnston MR,... |
Chemical analysis of four capsules containing the controlled substance... |
Forensic Sci Int |
2010 |
| Martínez-Clemente J, Escu... |
Interaction of mephedrone with dopamine and serotonin targets in rats |
Eur Neuropsychopharm... |
2011 |
| Jimenez M, Chiuve SE, Gly... |
Alcohol consumption and risk of stroke in women |
Stroke |
2012 |
| Cameron KN, Kolanos R, So... |
Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV)... |
Br J Pharmacol |
2012 |
| Cameron K, Kolanos R, Ver... |
Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents o... |
Psychopharmacology (... |
2013 |
| Daniulaityte R, Carlson R... |
I just wanted to tell you that loperamide WILL WORK: a web-based study... |
Drug Alcohol Depend |
2013 |
| McIntyre IM, Trochta A, S... |
Mitragynine 'Kratom' related fatality: a case report with postmortem c... |
J Anal Toxicol |
2015 |
| Csete J, Kamarulzaman A, ... |
Public health and international drug policy |
Lancet |
2016 |
| Xi-Ping Huang, Che T, Man... |
Pharmacology OF W-18 AND W-15 |
bioRxiv |
2016 |
| Elliott L, Benoit E, Camp... |
The long tail of a demon drug: The 'bath salts' risk environment |
Int J Drug Policy |
2017 |
| Ly C, Greb AC, Cameron LP... |
Psychedelics Promote Structural and Functional Neural Plasticity |
Cell Rep |
2018 |
| Meader N, Mdege N, McCamb... |
The public health evidence-base on novel psychoactive substance use: s... |
J Public Health (Oxf... |
2018 |
| Cameron LP, Benson CJ, De... |
Chronic, Intermittent Microdoses of the Psychedelic N, N-Dimethyltrypt... |
ACS Chem Neurosci |
2019 |
